Breda M, Martino F, Pastore G, Troncone L, Wuttge A
Strahlentherapie. 1982 Aug;158(8):480-3.
We have examined 16 patients with laryngeal carcinomas who had been submitted to laryngectomy and subsequent 60Co therapy (dose 60-70 Gy, thyroid exposure 50-60 Gy). After an interval of several years, some patients showed alterations of the thyroid function, i.e. a problematic hypothyreosis in two patients and a latent or compensated hypothyreosis in six patients. The latter could be demonstrated by several functional in-vitro tests (T3 saturation, T4, T3-RIA, TSHV, TRH). Especially the TRH test showed significant alterations in four patients. The results obtained from this relatively small number of cases correspond to the descriptions in literature of irradiation damages to the thyroid caused by the treatment of the laryngeal carcinoma. Despite the necessity of further control examinations of a greater number of patients, the results achieved hitherto suggest a prophylactic or substituting hormone treatment during the radiotherapy of the laryngeal carcinoma.
我们检查了16例接受喉切除术及随后钴-60治疗(剂量60 - 70 Gy,甲状腺受照剂量50 - 60 Gy)的喉癌患者。经过数年间隔,部分患者出现甲状腺功能改变,即2例患者存在有问题的甲状腺功能减退,6例患者存在潜伏性或代偿性甲状腺功能减退。后者可通过多项体外功能测试(T3饱和度、T4、T3放射免疫分析、TSHV、TRH)得以证实。尤其是TRH测试显示4例患者有显著改变。从这相对少数病例中获得的结果与文献中关于喉癌治疗导致甲状腺辐射损伤的描述相符。尽管有必要对更多患者进行进一步的对照检查,但迄今所取得的结果提示在喉癌放疗期间进行预防性或替代性激素治疗。